aabb-logo-sm

Cybersecurity in Blood and Biotherapies

The blood and biotherapies field faces unique and evolving challenges in cybersecurity. From safeguarding donor and patient data to ensuring the integrity of the blood supply chain, addressing these risks is critical for care and safety. Explore AABB's dedicated hub for cybersecurity resources tailored to leaders and professionals in this vital sector.

AABB Executive Cybersecurity Summit Recording

Get complimentary access to the full recording of the AABB Executive Cybersecurity Summit, held on October 18, in advance of the 2024 AABB Annual Meeting. This summit brought together top experts in the field, who provided critical strategies and insights to help organizations navigate the ever-evolving digital landscape.

A special thank you to our sponsor Digi-Trax for making this resource freely available to the community.

DIGI-TRAX - identify your future

View Recording

AABB Executive Cybersecurity Summit Program

Moderator: Dave Green, Chief Executive Officer, Vitalant

Panel 1: Cybersecurity Challenges and Strategies in Healthcare

  • CDR Thomas Cristl, Director, Office of Critical Infrastructure Protection, Administration for Strategic Preparedness and Response
  • Zach Nelson, CISSP GSOM GCTI, Vice President, Threat Operations Center, Health-ISAC (H-ISAC, Health Information Sharing and Analysis Center)
  • George Reeves, Supervisory Cybersecurity Advisor, Cybersecurity & Infrastructure Security Agency (CISA), Region VI, South Texas & New Mexico

Panel 2: Case Studies: Transfusion Medicine Lessons Learned from Cybersecurity Breaches

  • Susan Robinson, MBBS, MRCP, MSc, MDRes, FRCP, FRCPath, Guy’s and St Thomas Hospital
  • Sara Harm, MD, MSc, University of Vermont Medical Center
  • Martin Grable, EVP, Chief Financial and Administrative Officer, OneBlood 

Panel 3: Cybersecurity Challenges and Opportunities Related to the Blood Supply Chain

  • Vikas Mahajan, Vice President, Information Security, American Red Cross 
  • Bill Block, Chief Executive Officer, Blood Centers of America 
  • Anne Eder, MD, PhD, Director, Office of Blood Research & Review, U.S. Food and Drug Administration  

Additional Resources: